Longevity Health Holdings, Inc. Common Stock
XAGE
XAGE was delisted on the 11th of September, 2025.
15 hedge funds and large institutions have $62.2M invested in Longevity Health Holdings, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.43% more ownership
Funds ownership: 0% → 1.43% (+1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$14.4M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$14.4M |
| 3 |
AC
Antara Capital
New York
|
+$7.6M |
| 4 |
SC
Sculptor Capital
New York
|
+$7.12M |
| 5 |
Millennium Management
New York
|
+$3.87M |
Top Sellers
XAGE Hedge Fund Activity: Q3 2021 in Review
15 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Common Stock (XAGE) for Q3 2021, worth a combined $62.2M.
Buyers outnumbered sellers: 15 funds opened new XAGE positions and 0 closed out — a net gain of 15 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $14.4M.
- 15 institutional investors held Longevity Health Holdings, Inc. Common Stock (XAGE) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $62.2M of Longevity Health Holdings, Inc. Common Stock stock for Q3 2021.
- 15 funds opened new Longevity Health Holdings, Inc. Common Stock positions in Q3 2021 and 0 closed out, a net change of +15 holders.
- The largest Longevity Health Holdings, Inc. Common Stock buyer in Q3 2021 was Balyasny Asset Management, an estimated $14.4M added.
Based on aggregated 13F filings for Q3 2021.